OHSU in the news

Can ordinary COVID patients get the Trump treatment? It’s OK to ask

Kaiser Health News October 20, 2020
In an article describing what patients should consider before seeking experimental coronavirus treatments, Annette Totten, M.D., says: “The challenge is the evidence is not good because everything with COVID is new. I think it’s hard to cut through all the noise.”

Rural healthcare system struggling seven months into COVID-19

Capital Press October 20, 2020
In an editorial about unintended consequences of closing businesses to tame the pandemic, Robert Duehmig notes some health care works were laid off after non-essential procedures were temporarily halted. “Thanks to federal dollars, everybody’s still here. But some providers are just hanging on,” he says.

Ymir Genomics and Oregon Health & Science University announce agreement, co-discovery of robust urine biomarkers of liver disease, and patent application filing

Ymir Genomics October 20, 2020
Ymir Genomics LLC and the OHSU Knight Cancer Institute announce a licensing agreement and filed patent application to protect and promote newly-discovered high value urinary biomarkers for detecting cirrhosis and/or hepatocellular carcinoma (HCC) in at-risk patient populations. Christina Binder, M.D., Ph.D., says: “There is a real need for non-invasive, widely available biomarkers for cirrhosis and HCC. We believe this collaboration will further the work on early detection of these diseases."

Oregon health care systems created plans for surge in cases

KGW-TV October 20, 2020
Matthias Merkel, M.D., Ph.D., and David Zonies, M.D, M.P.H., M.B.A., say OHSU and other Oregon hospitals are better prepared for a potential surge of COVID patients this fall, including possibly accepting patients from other states, as needed.

OHSU paper urges more research into less invasive ventilation at end of life

Portland Business Journal October 19, 2020
A study co-authored by Donald Sullivan, M.D., recommends more research into less invasive ventilation: “More hospitalized patients are using non-invasive ventilation toward the end of their lives, even though there isn’t a lot of evidence that clearly lays out the therapy’s pros and cons.”
See more stories